Atara Biotherap
(ATRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,006 | -8,773 | -4,110 | N/A | N/A |
| Depreciation Amortization | 532 | 4 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -164 | 485 | 121 | N/A | N/A |
| Other Working Capital | -3 | 1,094 | 225 | N/A | N/A |
| Other Operating Activity | 11,013 | 1,224 | 2,939 | 0 | 0 |
| Operating Cash Flow | $-16,628 | $-5,966 | $-825 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -83,317 | N/A | N/A | N/A | N/A |
| PPE Investments | -46 | -3 | -9 | N/A | N/A |
| Investing Cash Flow | $-83,363 | $-3 | $-9 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 56,455 | N/A | 91 | N/A | N/A |
| Other Financing Activity | 13,818 | 53,377 | 4,950 | 0 | 0 |
| Financing Cash Flow | $70,273 | $53,377 | $5,041 | $N/A | $N/A |
| Beginning Cash Position | 51,615 | 4,207 | N/A | N/A | N/A |
| End Cash Position | 21,897 | 51,615 | 4,207 | N/A | N/A |
| Net Cash Flow | $-29,718 | $47,408 | $4,207 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,628 | -5,966 | -825 | N/A | N/A |
| Capital Expenditure | -46 | -3 | -9 | N/A | N/A |
| Free Cash Flow | -16,674 | -5,969 | -834 | 0 | 0 |